English (United Kingdom)Thai (ภาษาไทย)

Tentative result for EQAI 2016

 

 TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM

 

 TRIAL 01-16-4

Control material NO.

01-16-4-1

01-16-4-2

01-16-4-3

01-16-4-4

Non treponemal test

Non Reactive

Non Reactive  

NS

Reactive

Treponemal test

Reactive

Reactive

Reactive

Reactive

 
 
 
TENTATIVE DESIGNATED RESPONSE FOR HEPATTTIS B VIRUS
SEROLOGY PROGRAM
 
 

TRIAL 02-16-4

Control material NO.

02-16-4-1

02-16-4-2

02-16-4-3

02-16-4-4

HBsAg

POSITIVE
899.57±108.99
(ECLIA)

POSITIVE
744.45±89316
(ECLIA)

NEGATIVE
0.53±0.13
(ECLIA)

NEGATIVE
0.52± 0.14
(ECLIA)

antiHBs
(all methods)
(mIU/ml)

NEGATIVE
0.70±1.31

NEGATIVE
0.70±1.49

POSITIVE
542.61±153.62

POSITIVE
322.57±105.91      

antiHBc

POSITIVE

NS

POSITIVE

POSITIVE

HBeAg

NEGATIVE

NEGATIVE

NEGATIVE

NEGATIVE

antiHBe

POSITIVE

POSITIVE

POSITIVE

POSITIVE

 
 

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM

 

TRIAL 01-16-3

Control material NO.

01-16-3-1

01-16-3-2

01-16-3-3

01-16-3-4

Non treponemal test

Reactive

Reactive

Non Reactive

NS

Treponemal test

Reactive

Reactive

Reactive

Reactive

 
 
TENTATIVE DESIGNATED RESPONSE FOR HEPATTTIS B VIRUS
SEROLOGY PROGRAM
 
 

 TRIAL 02-16-3

Control material NO.

02-16-3-1

02-16-3-2

02-16-3-3

02-16-3-4

HBsAg

NEGATIVE
0.51±0.12
(ECLIA)

NEGATIVE
0.49±0.15
(ECLIA)

POSITIVE
690.69±67.44
(ECLIA)

POSITIVE
1,084.51± 120.03
(ECLIA)

antiHBs
(all methods)
(mIU/ml)

POSITIVE
424.87±89.98

POSITIVE
97.57±18.50

NEGATIVE
0.47±0.86

NEGATIVE
0.58±0.80      

antiHBc

NS

NS

NS

POSITIVE

HBeAg

NEGATIVE

NEGATIVE

POSITIVE

NEGATIVE

antiHBe

NEGATIVE

POSITIVE

NEGATIVE

POSITIVE

 
 

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM

 

TRIAL 01-16-2

Control material NO.

01-16-2-1

01-16-2-2

01-16-2-3

01-16-2-4

Non treponemal test

Reactive

Reactive

Reactive

NS

Treponemal test

Reactive

Reactive

Reactive

Reactive

 
 
TENTATIVE DESIGNATED RESPONSE FOR HEPATTTIS B VIRUS
SEROLOGY PROGRAM
 

TRIAL 02-16-2 

Control material NO.

02-16-2-1

02-16-2-2

02-16-2-3

02-16-2-4

HBsAg

NS
28.52±4.50
(ECLIA)

NEGATIVE
0.54±0.14
(ECLIA)

POSITIVE
326.01±48.58
(ECLIA)

NEGATIVE
0.55± 0.15
(ECLIA)

antiHBs
(all methods)
(mIU/ml)

NEGATIVE
1.25±3.68

POSITIVE
149.44±34.26

NEGATIVE
0.76±1.16

POSITIVE
253.74±93.28

antiHBc

NS

NS

NS

NS

HBeAg

NEGATIVE

NEGATIVE

NEGATIVE

NEGATIVE

antiHBe

POSITIVE

POSITIVE

POSITIVE

POSITIVE

 
 
TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM
   
 

TRIAL 01-16-1

 
 

Control material NO.

01-16-1-1

01-16-1-2

01-16-1-3

01-16-1-4

Non treponemal test

Reactive

Reactive

Non Reactive

Non Reactive

Treponemal test

Reactive

Reactive

Reactive

Reactive

 
   
TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS
SEROLOGY PROGRAM
   
 

TRIAL 02-16-1

 
 

Control material NO.

02-16-1-1

02-16-1-2

02-16-1-3

02-16-1-4

HBsAg

NEGATIVE
0.53± 0.18(ECLIA)

NEGATIVE
0.58± 0.09(ECLIA)

POSITIVE
167.29± 19.51(ECLIA)

POSITIVE
624.56± 59.62(ECLIA)

antiHBs
(all methods)
(mIU/ml)

POSITIVE
148.06 ±16.53

POSITIVE
88.20 ± 52.11

NEGATIVE
0.88± 1.10

NEGATIVE
0.74±0.85

antiHBc

NS

NS

NS

POSITIVE

HBeAg

NEGATIVE

NEGATIVE

NEGATIVE

NEGATIVE

antiHBe

NS

NS

POSITIVE

POSITIVE

 

 

 

 


Copyright © 2010 Faculty of Medical Technology, Mahidol University. All Rights Reserved. Download Internet Explorer 8 Top